{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:54:20Z","timestamp":1791446060111,"version":"4.3.3"},"reference-count":48,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026163","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T07:52:41Z","timestamp":1788162761000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Integrated metabolomics and machine learning for coronary artery disease severity stratification: identification of plasma metabolic signatures"],"prefix":"10.3724","author":[{"given":"Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoling","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrg.2016.160","volume":"18","author":"Khera AV","year":"2017","unstructured":"Khera AV, Kathiresan S. Genetics of coronary artery disease: Discovery, biology and clinical translation. Nat Rev Genet, 2017, 18: 331-344.","journal-title":"Nat Rev Genet"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41569-021-00638-w","volume":"19","author":"Klarin D","year":"2022","unstructured":"Klarin D, Natarajan P. Clinical utility of polygenic risk scores for coronary artery disease. Nat Rev Cardiol, 2022, 19: 291-301.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION3","unstructured":"G.A. Roth, G.A. Mensah, C.O. Johnson, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study (vol 76, pg 2982, 2020).  J Am Coll Cardiol  2021, 77: 1958\u20131959."},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"e069397","DOI":"10.1136\/bmjopen-2022-069397","volume":"13","author":"Wu S","year":"2023","unstructured":"Wu S, Xu W, Guan C, Lv M, Jiang S, Jinhua Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990\u20132019: an analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open, 2023, 13:","journal-title":"BMJ Open"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/heartjnl-2024-324650","volume":"111","author":"Wang R","year":"2025","unstructured":"Wang R, Wang Y, Lu J, Li Y, Wu C, Yang Y, Cui J. Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort. Heart, 2025, 111: 205-211.","journal-title":"Heart"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1093\/eurheartj\/ehae465","volume":"45","author":"L\u00fcscher TF","year":"2024","unstructured":"L\u00fcscher TF, Wenzl FA, D\u2032Ascenzo F, Friedman PA, Antoniades C. Artificial intelligence in cardiovascular medicine: clinical applications. Eur Heart J, 2024, 45: 4291-4304.","journal-title":"Eur Heart J"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.3390\/ijms23168939","volume":"23","author":"Meng H","year":"2022","unstructured":"Meng H, Ruan J, Yan Z, Chen Y, Liu J, Li X, Meng F. New progress in early diagnosis of atherosclerosis. Int J Mol Sci, 2022, 23:","journal-title":"Int J Mol Sci"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","volume":"139","author":"Tamis-Holland JE","year":"2019","unstructured":"Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association. Circulation, 2019, 139: e891-e908.","journal-title":"Circulation"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1259\/bjr\/15296170","volume":"85","author":"Sun Z","year":"2012","unstructured":"Sun Z, Choo GH, Ng KH. Coronary CT angiography: current status and continuing challenges. BJR, 2012, 85: 495-510.","journal-title":"BJR"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","volume":"15","author":"Lv J","year":"2024","unstructured":"Lv J, Pan C, Cai Y, Han X, Wang C, Ma J, Pang J. Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nat Commun, 2024, 15:","journal-title":"Nat Commun"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","volume":"44","author":"Nurmohamed NS","year":"2023","unstructured":"Nurmohamed NS, Kraaijenhof JM, Mayr M, Nicholls SJ, Koenig W, Catapano AL, Stroes ESG. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J, 2023, 44: 1594-1607.","journal-title":"Eur Heart J"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41591-022-01686-6","volume":"28","author":"Talmor-Barkan Y","year":"2022","unstructured":"Talmor-Barkan Y, Bar N, Shaul AA, Shahaf N, Godneva A, Bussi Y, Lotan-Pompan M. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat Med, 2022, 28: 295-302.","journal-title":"Nat Med"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"15676","DOI":"10.1038\/s41598-025-99944-3","volume":"15","author":"Urbanowicz T","year":"2025","unstructured":"Urbanowicz T, Gutaj P, Plewa S, Spasenenko I, Olasi\u0144ska-Wi\u015bniewska A, Krasi\u0144ska B, Tykarski A. Obesity and acylcarnitine derivates interplay with coronary artery disease. Sci Rep, 2025, 15:","journal-title":"Sci Rep"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"Johnson CH","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol, 2016, 17: 451-459.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"Qiu S","year":"2023","unstructured":"Qiu S, Cai Y, Yao H, Lin C, Xie Y, Tang S, Zhang A. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Sig Transduct Target Ther, 2023, 8:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","volume":"20","author":"Rinschen MM","year":"2019","unstructured":"Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol, 2019, 20: 353-367.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","volume":"7","author":"Liu H","year":"2019","unstructured":"Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, Pang H. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome, 2019, 7:","journal-title":"Microbiome"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0140-6736(22)02079-7","volume":"401","author":"Forrest IS","year":"2023","unstructured":"Forrest IS, Petrazzini BO, Duffy \u00c1, Park JK, Marquez-Luna C, Jordan DM, Rocheleau G. Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts. Lancet, 2023, 401: 215-225.","journal-title":"Lancet"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.scib.2024.03.053","volume":"69","author":"Guo B","year":"2024","unstructured":"Guo B, Jiang M, Guo X, Tang C, Zhong J, Lu M, Liu C. Diagnostic and prognostic performance of artificial intelligence-based fully-automated on-site CT-FFR in patients with CAD. Sci Bull, 2024, 69: 1472-1485.","journal-title":"Sci Bull"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"117238","DOI":"10.1016\/j.atherosclerosis.2023.117238","volume":"381","author":"Lee YH","year":"2023","unstructured":"Lee YH, Hsieh MT, Chang CC, Tsai YL, Chou RH, Lu HHS, Huang PH. Improving detection of obstructive coronary artery disease with an artificial intelligence-enabled electrocardiogram algorithm. Atherosclerosis, 2023, 381:","journal-title":"Atherosclerosis"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.gpb.2023.01.002","volume":"20","author":"Gao F","year":"2022","unstructured":"Gao F, Huang K, Xing Y. Artificial intelligence in omics. Genomics Proteomics BioInf, 2022, 20: 811-813.","journal-title":"Genomics Proteomics BioInf"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","volume":"12","author":"Mann M","year":"2021","unstructured":"Mann M, Kumar C, Zeng WF, Strauss MT. Artificial intelligence for proteomics and biomarker discovery. Cell Syst, 2021, 12: 759-770.","journal-title":"Cell Syst"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1021\/acs.analchem.1c05502","volume":"94","author":"Ding X","year":"2022","unstructured":"Ding X, Yang F, Chen Y, Xu J, He J, Zhang R, Abliz Z. Norm ISWSVR: a data integration and normalization approach for large-scale metabolomics. Anal Chem, 2022, 94: 7500-7509.","journal-title":"Anal Chem"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/metabo10010008","volume":"10","author":"Reisdorph NA","year":"2020","unstructured":"Reisdorph NA, Walmsley S, Reisdorph R. A Perspective and framework for developing sample type specific databases for LC\/MS-based clinical metabolomics. Metabolites, 2020, 10:","journal-title":"Metabolites"},{"key":"CITATION25","doi-asserted-by":"crossref","unstructured":"S.A. Sansone, T. Fan, R. Goodacre, et al. The metabolomics standards initiative.  Nat Biotechnol  2007, 25: 846\u2013848.","DOI":"10.1038\/nbt0807-846b"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s44161-021-00009-1","volume":"1","author":"Koplev S","year":"2022","unstructured":"Koplev S, Seldin M, Sukhavasi K, Ermel R, Pang S, Zeng L, Bankier S. A mechanistic framework for cardiometabolic and coronary artery diseases. Nat Cardiovasc Res, 2022, 1: 85-100.","journal-title":"Nat Cardiovasc Res"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12944-022-01696-w","volume":"21","author":"Liao Y","year":"2022","unstructured":"Liao Y, Dong Z, Liao H, Chen Y, Hu L, Yu Z, Xia Y. Lipid metabolism patterns and relevant clinical and molecular features of coronary artery disease patients: an integrated bioinformatic analysis. Lipids Health Dis, 2022, 21:","journal-title":"Lipids Health Dis"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1612790","volume":"377","author":"Dewey FE","year":"2017","unstructured":"Dewey FE, Gusarova V, Dunbar RL, O\u2032Dushlaine C, Schurmann C, Gottesman O, McCarthy S. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med, 2017, 377: 211-221.","journal-title":"N Engl J Med"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"Weber C","year":"2011","unstructured":"Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 2011, 17: 1410-1422.","journal-title":"Nat Med"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41467-022-28240-9","volume":"13","author":"Lebeau PF","year":"2022","unstructured":"Lebeau PF, Byun JH, Platko K, Saliba P, Sguazzin M, MacDonald ME, Par\u00e9 G. Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance. Nat Commun, 2022, 13:","journal-title":"Nat Commun"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1080\/15548627.2021.2021494","volume":"18","author":"Tripathi M","year":"2022","unstructured":"Tripathi M, Singh BK, Liehn EA, Lim SY, Tikno K, Castano-Mayan D, Rattanasopa C. Caffeine prevents restenosis and inhibits vascular smooth muscle cell proliferation through the induction of autophagy. Autophagy, 2022, 18: 2150-2160.","journal-title":"Autophagy"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/aps.2018.24","volume":"39","author":"Nayeem MA","year":"2018","unstructured":"Nayeem MA. Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin, 2018, 39: 1142-1154.","journal-title":"Acta Pharmacol Sin"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.3390\/nu16223812","volume":"16","author":"A\u011fag\u00fcnd\u00fcz D","year":"2024","unstructured":"A\u011fag\u00fcnd\u00fcz D, Ye\u015fildemir \u00d6, Ko\u00e7yi\u011fit E, Ko\u00e7ak T, \u00d6zen \u00dcnald\u0131 B, Ayakda\u015f G, Bud\u00e1n F. Oxylipins derived from PUFAs in cardiometabolic diseases: mechanism of actions and possible nutritional interactions. Nutrients, 2024, 16:","journal-title":"Nutrients"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"102160","DOI":"10.1016\/j.plefa.2020.102160","volume":"160","author":"Du Y","year":"2020","unstructured":"Du Y, Taylor CG, Aukema HM, Zahradka P. Role of oxylipins generated from dietary PUFAs in the modulation of endothelial cell function. Prostaglandins Leukotrienes Essential Fatty Acids, 2020, 160:","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.plipres.2022.101165","volume":"86","author":"Dyall SC","year":"2022","unstructured":"Dyall SC, Balas L, Bazan NG, Brenna JT, Chiang N, da Costa Souza F, Dalli J. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions. Prog Lipid Res, 2022, 86:","journal-title":"Prog Lipid Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-arplant-042817-040440","volume":"69","author":"Wasternack C","year":"2018","unstructured":"Wasternack C, Feussner I. The oxylipin pathways: biochemistry and function. Annu Rev Plant Biol, 2018, 69: 363-386.","journal-title":"Annu Rev Plant Biol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11883-009-0061-3","volume":"11","author":"Shearer GC","year":"2009","unstructured":"Shearer GC, Newman JW. Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Curr Atheroscler Rep, 2009, 11: 403-410.","journal-title":"Curr Atheroscler Rep"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12933-025-02614-x","volume":"24","author":"Wang Z","year":"2025","unstructured":"Wang Z, Wu C, Yin D, Dou K. Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases. Cardiovasc Diabetol, 2025, 24:","journal-title":"Cardiovasc Diabetol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/ijms20051051","volume":"20","author":"Solati Z","year":"2019","unstructured":"Solati Z, Ravandi A. Lipidomics of bioactive lipids in acute coronary syndromes. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1111\/j.1750-3841.2010.01561.x","volume":"75","author":"Heckman MA","year":"2010","unstructured":"Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci, 2010, 75: R77-R87.","journal-title":"J Food Sci"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMra1816604","volume":"383","author":"Campion EW","year":"2020","unstructured":"Campion EW, van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med, 2020, 383: 369-378.","journal-title":"N Engl J Med"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40290-023-00466-y","volume":"37","author":"Khiali S","year":"2023","unstructured":"Khiali S, Agabalazadeh A, Sahrai H, Bannazadeh Baghi H, Rahbari Banaeian G, Entezari-Maleki T. Effect of caffeine consumption on cardiovascular disease: an updated review. Pharm Med, 2023, 37: 139-151.","journal-title":"Pharm Med"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2013.06.035","volume":"62","author":"O\u2032Keefe JH","year":"2013","unstructured":"O\u2032Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol, 2013, 62: 1043-1051.","journal-title":"J Am Coll Cardiol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41569-022-00719-4","volume":"19","author":"van Dam RM","year":"2022","unstructured":"van Dam RM, Hu FB. Caffeine consumption and cardiovascular health. Nat Rev Cardiol, 2022, 19: 429-430.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0006-2952(94)90173-2","volume":"47","author":"Farag MM","year":"1994","unstructured":"Farag MM, Abdel-Meguid EM. Hepatic glutathione and lipid peroxidation in rats treated with theophylline. Biochem Pharmacol, 1994, 47: 443-446.","journal-title":"Biochem Pharmacol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0009-8981(00)00201-1","volume":"295","author":"Lee C","year":"2000","unstructured":"Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta, 2000, 295: 141-154.","journal-title":"Clin Chim Acta"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/life12111933","volume":"12","author":"Sayadi M","year":"2022","unstructured":"Sayadi M, Varadarajan V, Sadoughi F, Chopannejad S, Langarizadeh M. A machine learning model for detection of coronary artery disease using noninvasive clinical parameters. Life, 2022, 12:","journal-title":"Life"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"632950","DOI":"10.3389\/fmolb.2021.632950","volume":"8","author":"Chen H","year":"2021","unstructured":"Chen H, Wang Z, Qin M, Zhang B, Lin L, Ma Q, Liu C. Comprehensive metabolomics identified the prominent role of glycerophospholipid metabolism in coronary artery disease progression. Front Mol Biosci, 2021, 8:","journal-title":"Front Mol Biosci"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/27AAC43D83014CC788973A8B852B59DB","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/27AAC43D83014CC788973A8B852B59DB","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:19:22Z","timestamp":1791443962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":48,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026163","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}